Drug Shortage Report for APO-RISEDRONATE
Report ID | 484 |
Drug Identification Number | 02377721 |
Brand name | APO-RISEDRONATE |
Common or Proper name | RISEDRONATE |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | RISEDRONATE SODIUM |
Strength(s) | 150MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 1 BLS |
ATC code | M05BA |
ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-02-14 |
Estimated end date | 2017-03-15 |
Actual end date | 2017-03-14 |
Shortage status | Resolved |
Updated date | 2017-03-15 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2017-03-15 | French | Compare |
v4 | 2017-03-15 | English | Compare |
v3 | 2017-03-11 | French | Compare |
v2 | 2017-03-11 | French | Compare |
v1 | 2017-03-11 | English | Compare |
Showing 1 to 5 of 5